ADX88178, a selective mGluR4 PAM, exerts long-term therapeutic effects in RR-EAE.
ADX88178 activates a noncanonical mGluR4 signaling in DCs.
ADX88178 induces a tolerogenic functional phenotype in DCs via immunoregulatory IDO1.
Highly selective mGluR4 PAMs may represent novel drugs in chronic neuroinflammation.